How much does a medical practice valuation cost in Australia?

The short answer

For a straightforward Australian general practice — one operating entity, clean records, a current valuation date — a signed Prismi valuation typically starts at the Comprehensive tier, from $3,995 + GST, because a trading practice almost always needs dual methodology, normalised earnings and a documented goodwill-split analysis. Where the practice runs the common service-entity structure, the additional entity adds $750, bringing a typical engagement to $4,745 + GST. Multi-practitioner practices with mixed arrangements, small business CGT concession claims and matters likely to be reviewed sit at the Defensible Valuation File tier, from $8,995 + GST. Across the wider market, full valuation reports at traditional firms typically run $5,000–$15,000 or more, and most providers do not publish a fee at all — you find out by requesting a quote. Healthcare-specialist advisers and practice brokers also offer appraisals, some free; these serve a sale-campaign purpose and are not signed valuation evidence. The honest headline, though, is not the number — it is why medicine costs more to value than a trades business or a retail shop with the same revenue. The answer is practitioner dependency, and it shapes every fee in this article.

The goodwill split: the scope item that defines a medical valuation

In most small businesses, goodwill is a single question: how much is there. In a medical practice, it is two questions: how much is there, and how much of it actually transfers. Personal goodwill — the patients who book because of a specific doctor, the referrers who refer to a specific practitioner — attaches to the person and leaves with them. Practice goodwill — the location, the brand, the appointment systems, the nurse-led services, the contracted doctor cohort, the patient database — attaches to the entity and can be sold. Market value is a price for what remains after the vendor departs, so the split is not a refinement; it is the valuation. Settling it takes analysis a generic small-business engagement never performs: billings broken down by practitioner to see who actually generates the earnings; patient re-booking patterns, to test whether patients follow the clinic or the clinician; and the contract terms — whether doctor agreements are written, current, assignable, and carry restraints that would actually hold. That work is why the realistic starting tier for a trading practice is Comprehensive rather than Essential, and it is the single biggest driver of the gap between a medical valuation fee and a generic one. The full framework is set out at /insights/personal-vs-transferable-goodwill.

Prismi's fixed fees for medical practice valuations

Three surcharges apply, all defined before you engage rather than discovered on an invoice: additional entities add $750 each — relevant to almost every practice, because the operating entity plus service trust pairing is the standard structure; retrospective valuation dates add $495 per historical date; and rush turnaround adds 30%, subject to capacity. Every fee is fixed at engagement, never billed by the hour, and never contingent on the outcome. Every report is senior-reviewer signed under an independence statement, prepared with the ATO's market valuation guidance and IVS 104 in mind, and the working file behind it is retained for ten years.

What pushes a practice valuation fee up

The base tiers assume a defined scope. These are the features that expand it — each one is more analysis, not padding:

• ·Multiple practitioners on differing arrangements — a practice with a principal, two percentage-of-billings contractors and a salaried GP registrar has four different earnings and dependency profiles, and each needs its own billings and normalisation analysis
• ·Service entities and trusts — each additional entity valued adds $750, and the analysis must trace how fees flow between the practice, the service entity and the practitioners
• ·Co-located allied health, pathology rent or treatment-room licensing income — separate earnings streams with different risk, different maintainability and different transferability, each assessed on its own evidence
• ·Owner-doctor clinical earnings mixed into profit — where the principal has never drawn a market-rate clinical wage, the normalisation work is heavier and the value impact larger
• ·Retrospective valuation dates — historical dates add $495 each and restrict the evidence to what was reasonably knowable at the time
• ·Contested context — partner buy-in disputes, family law adjacency or realistic ATO review risk push the engagement up a tier rather than adding a surcharge, because the file needs to be built for challenge from the start

The ecosystem problem: service entities and associateship models

Ask what a medical practice is worth and the first professional question back is: which entity, exactly? Most established practices are not one business but an ecosystem. A common structure runs a service entity — often a trust — that owns the premises fit-out, employs the reception and nursing staff and supplies rooms and administration to the doctors, who practise as independent contractors paying a service fee, frequently a percentage of their billings. In associateship models, practitioners may hold interests in the service entity without any entity ever owning the patients or the billings. So the valuation scope has to be defined before the methodology starts: is the subject the service entity's maintainable service-fee stream, the operating practice entity, a specific doctor's interest, or the combined ecosystem a buyer would actually acquire? Each answer produces a different analysis, and getting it wrong produces a technically tidy report about the wrong asset. This is a second reason medical engagements carry more scope than generic ones — the valuer is frequently valuing two or three entities and the arrangements between them, not one set of accounts. It is also why the additional-entity surcharge exists as a published line item rather than a quiet quote adjustment.

Medicare, bulk-billing and the earnings evidence

A maintainable earnings conclusion is only as strong as its evidence, and in a medical practice the earnings evidence runs through the payer. The valuer reviews Medicare billing profiles by practitioner — item mix, billings per session, consistency over time — because these are the substantiation behind any claim about what the practice can sustainably earn. Billing mix matters to risk: a heavily bulk-billed practice has earnings that move with Medicare rebate settings and incentive programs, while a private-billing practice carries different sensitivity, and the multiple should reflect whichever exposure the evidence shows. Two further review items sit in the same category. State payroll tax treatment of payments flowing to contractor doctors has shifted materially in recent years and now varies by state — with relief in some states tied to GP status or bulk-billing thresholds — so a supportable valuation documents the practice's position rather than assuming the exposure away, since it directly affects maintainable earnings and any historical liability a buyer would price. And accreditation status and Medicare compliance history bear on whether the earnings are durable at all. None of this makes the valuer a tax or health-regulation adviser — Prismi values the practice and documents the evidence; the payroll tax position and compliance questions themselves belong with the practice's accountant and lawyer. But a medical valuation that has not looked at any of it is not evidence, and reviewing it is part of what the fee buys.

The honest trade-off: when the cheapest tier is the wrong tier

Fixed-fee pricing only stays honest if the limits are published alongside the prices. The Essential tier is a single-methodology report: one accepted method applied properly to clean records at a current date, evidence documented, senior-reviewer signed. Its fixed scope is exactly why it can be priced from $1,495 + GST without being thin — but a single methodology cannot carry a goodwill-split question, and it is not suited to contested matters, family law, or positions with realistic ATO-dispute risk. For most trading practices that makes Essential the wrong tier, and we will say so at scoping rather than take the engagement. Step up to the Defensible Valuation File when any of these apply: the valuation supports a small business CGT concession claim under Division 152, where the $6m maximum net asset value test turns on market value; the transfer is between related parties — a practice interest moving to a family trust, a restructure or incorporation — where market value substitution under s 116-30 can apply; a partner buy-in or buy-out where the other side has its own advisers; or a structure where multiple entities and differing practitioner arrangements make the earnings evidence genuinely contestable. The arithmetic favours candour: stepping up at engagement costs thousands, while a thin valuation that fails under review costs a second valuation, a weakened position, and potentially amended assessments. Fixed-scope efficiency is the pitch; corner-cutting is not.

Scoping your practice valuation

The fastest way to an accurate fixed fee is to send the shape of the practice before anyone commits: a simple structure diagram showing the entities and who owns what; financial statements for each entity for the last three to five years; billings by practitioner; the doctor agreements and service agreements; and the purpose and valuation date. From that, the tier, the entity count and any surcharges are determinable up front — and the fee is then fixed, whatever the analysis finds. Two companion pages complete the picture: what practices actually sell for, including multiples and the owner-wage normalisation that surprises most principals, is at /insights/how-much-is-a-medical-practice-worth-australia, and the full industry methodology sits at /industries/medical-and-dental-practices. One boundary stated plainly, as always: Prismi prepares independent valuations only. We are not registered tax agents and do not provide tax, legal or financial advice — concession eligibility, payroll tax exposure and transaction structure are matters for your accountant and lawyer, working from the valuation evidence. Our part is a supportable value for the right asset, at a fee you knew before we started.